Dr. Polkinghorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1155 4th Street
Suite 405
San Francisco, CA 94158Phone+1 917-370-8197
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2007 - 2012
Massachusetts General HospitalResidency, Pediatrics, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
NY State Medical License 2008 - 2022
Publications & Presentations
PubMed
- 31 citationsOncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3Cβ D1067V kinase domain mutationEvangelos Pazarentzos, Petros Giannikopoulos, Gorjan Hrustanovic, J St John, Victor Olivas
Oncogene. 2016-03-03 - 98 citationsAndrogen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.Daniel E. Spratt, Michael J. Evans, Brian J. Davis, Michael G. Doran, Man Xia Lee
Cancer Research. 2015-11-15 - 137 citationsThe Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam...Zachary S. Zumsteg, Daniel E. Spratt, Paul B. Romesser, Xin Pei, Zhigang Zhang
European Urology. 2015-06-01
Press Mentions
‘We Ran Out of Money’: High-Profile Startup Seeking to Connect Patients with Clinical Trials Shuts DownNovember 12th, 2018
Driver's High-Cost Cancer Care Procurement App Shutters Shortly After LaunchNovember 12th, 2018
Driver Launches Its Platform to Connect Cancer Patients to the Best TreatmentsSeptember 9th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
